Sandoz Group AG (XSWX:SDZ) Other Gross PPE: CHF2,263 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSWX:SDZ Sandoz Group AG XSWX:SDZ
26 GF Score
Price CHF67.76
GF Value CHF47.01
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Sandoz Group AG Other Gross PPE?

Sandoz Group AG XSWX:SDZ -0.65% 26 Other Gross PPE is CHF2,263 Mil as of Jun. 2026. GuruFocus rates XSWX:SDZ with a GF Score™ of 26/100 and a GF Value™ of CHF47.01 (Significantly Overvalued). The stock has 6 warning signs investors should review.

Sandoz Group AG's Other Gross PPE for the quarter that ended in Jun. 2026 was CHF2,263 Mil.

Sandoz Group AG's quarterly Other Gross PPE declined from Jun. 2025 (CHF1,895 Mil) to Dec. 2025 (CHF38 Mil) but then increased from Dec. 2025 (CHF38 Mil) to Jun. 2026 (CHF2,263 Mil).

Sandoz Group AG's annual Other Gross PPE declined from Dec. 2023 (CHF34 Mil) to Dec. 2024 (CHF33 Mil) but then increased from Dec. 2024 (CHF33 Mil) to Dec. 2025 (CHF38 Mil).

Sandoz Group AG Other Gross PPE Historical Data

* Premium members only.

The historical data trend for Sandoz Group AG's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sandoz Group AG Other Gross PPE Chart

Sandoz Group AG Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Other Gross PPE
12.11 33.73 32.99 38.25

Sandoz Group AG Semi-Annual Data
Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Other Gross PPE Get a 7-Day Free Trial 1,700.01 32.99 1,894.76 38.25 2,262.82
XSWX:SDZ
26GF Score
Sandoz Group AG XSWX:SDZ
Other Gross PPE is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sandoz Group AG Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.

Frequently Asked Questions Learn more about Other Gross PPE →
What does a Other Gross PPE of CHF2,263 Mil mean?
Sandoz Group AG (XSWX:SDZ) has a Other Gross PPE of CHF2,263 Mil as of Jun. 2026. Other Gross PPE is property, plant and equipment recorded on a company's balance sheet that not otherwise classified. View historical data on Sandoz Group AG and its competitors.
Is Sandoz Group AG's Other Gross PPE too high?
Sandoz Group AG's current Other Gross PPE is CHF2,263 Mil. Overall, Sandoz Group AG has a GF Score™ of 26/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Sandoz Group AG's Other Gross PPE compare to ZTS and UTHR?
Sandoz Group AG's Other Gross PPE of CHF2,263 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Gross PPE for a Drug Manufacturers company?
A good Other Gross PPE depends on the Drug Manufacturers industry context. However, Other Gross PPE should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Gross PPE mean?
A high Other Gross PPE can signal that a stock is expensive relative to its fundamentals. Other Gross PPE is property, plant and equipment recorded on a company's balance sheet that not otherwise classified. View historical data on Sandoz Group AG and its competitors. Sandoz Group AG's current Other Gross PPE is CHF2,263 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sandoz Group AG stock overvalued right now?
Based on GuruFocus' analysis, Sandoz Group AG (XSWX:SDZ) is currently considered Significantly Overvalued. The stock's GF Value™ is CHF47.01, compared to a current price of CHF67.76 — trading 44.1% above its estimated fair value. The current Other Gross PPE is CHF2,263 Mil. Sandoz Group AG's overall GF Score™ is 26/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Gross PPE calculated?
Other Gross PPE is calculated from a company's financial statements. For Sandoz Group AG (XSWX:SDZ), the current Other Gross PPE is CHF2,263 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sandoz Group AG (XSWX:SDZ) Overvalued in 2026?

Based on GuruFocus' analysis, Sandoz Group AG stock appears to be overvalued. The current stock price of CHF67.76 is trading 44.1% above its estimated GF Value™ of CHF47.01. GuruFocus considers Sandoz Group AG to be Significantly Overvalued.

Key valuation signals for XSWX:SDZ:

  • Other Gross PPE: CHF2,263 Mil
  • GF Value™: CHF47.01 vs. price of CHF67.76 (44.1% above fair value)
  • GF Score™: 26/100 with 6 warning signs

No single metric tells the full story. See the XSWX:SDZ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sandoz Group AG Business Description

Address Centralbahnstrasse 4, Basel, CHE, 4051
Sandoz is one of the largest generic pharmaceutical manufacturers in the world, generating over $11 billion annually from off-patent drugs. Once part of Novartis, Sandoz spun off and went public in October 2023. Generics, including small molecules and complex injectables, make up roughly 75% of Sandoz's total sales, and the firm has a significant presence in Europe, the United States, and other key international markets. Sandoz generates its remaining sales from biosimilars and is among the leaders in the space. Sandoz launched Europe's first biosimilar, Omnitrope, in 2006, as well as the first US biosimilar, Zarxio, in 2015. It has over 10 launched biosimilars in a number of markets and over 20 assets in its pipeline.
26GF Score

Get the complete analysis for XSWX:SDZ

Other Gross PPE is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF67.76
Price
CHF47.01
GF Value